| AI | artificial intelligence |
| AOIs | areas of illumination |
| CNBs | core needle biopsies |
| CT | tumor center |
| CTA | Cancer Transcriptome Atlas |
| DCIS | ductal carcinoma in situ |
| DFS | disease free survival |
| DSP | Digital Spatial Profiler |
| ECM | extracellular matrix |
| ER | estrogen receptor |
| FFPE | formalin-fixed paraffin-embedded |
| GBCC | GeoMx Breast Cancer Consortium |
| GSEA | gene set enrichment analysis |
| H&E | hematoxylin and eosin |
| HCA | Human Cell Atlas |
| HER2 | epidermal growth factor receptor 2 |
| HK | housekeeping |
| HuBMAP | Human Biomolecular Atlas Program |
| IDC | invasive ductal carcinoma |
| IgG | immunoglobulin G |
| IHC | immunohistochemistry |
| ILC | invasive lobular carcinoma |
| IM | invasive margin |
| LCIS | lobular carcinoma in situ |
| MIAME | Minimum Information About a Microarray Experiment |
| MINSEQE | Minimum Information About a Next-generation Sequencing Experiment |
| NGS | next generation sequencing |
| PanCK | pan-cytokeratin |
| PCA | principal component analysis |
| pCR | pathological complete response |
| PD | pharmacodynamic |
| PR | progesterone receptor |
| ROIs | regions of interest |
| TILs | tumor-infiltrating lymphocytes |
| TMA | tissue microarray |
| TME | tumor microenvironment |
| TMM | trimmed mean of M values |
| TNBC | triple-negative breast cancer |
| tSNE | t-distributed stochastic neighbor embedding |
| UMAP | uniform manifold approximation and projection |
| UV | ultraviolet |
| WTA | Whole Transcriptome Atlas |